Phase 1 Inflammatory Bowel Diseases Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
Inflammatory Bowel DiseasesUlcerative ColitisClostridioides Difficile Infection
University of Alberta85 enrolled2 locationsNCT07401680
Recruiting
Phase 1
Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Inflammatory Bowel Diseases
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.135 enrolled30 locationsNCT06754891
Recruiting
Phase 1Phase 2
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Children's Hospital Medical Center, Cincinnati116 enrolled3 locationsNCT03847467
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD
Inflammatory Bowel Diseases
The Foundation for Orthopaedics and Regenerative Medicine15 enrolled2 locationsNCT05003947
Recruiting
Phase 1Phase 2
Microbial Restoration in Inflammatory Bowel Diseases
Inflammatory Bowel DiseasesCrohn DiseaseMicrobiome+1 more
St Vincent's Hospital Melbourne120 enrolled1 locationNCT04970446
Recruiting
Phase 1
Phase 1 Study for IPG11406 in Health Volunteer
Inflammatory Bowel Diseases
Nanjing Immunophage Biotech Co., Ltd66 enrolled1 locationNCT06255834
Recruiting
Phase 1Phase 2
Beta-Hydroxybutyrate Feasibility Treating IBD
Inflammatory Bowel DiseasesCrohn's Disease
University of Texas at Austin20 enrolled1 locationNCT06351124